Physician profile
John C Marzano
NPI 1497719694
$4,166.67
in general payments reported to CMS, 2019-2025
25 companies · $779 in 2025
The $779 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $159 · 2021: $619 · 2022: $683 · 2023: $693 · 2024: $849 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,321.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,157.03 | 2019-2025 | Puraply, Apligraf, Cygnus Dual |
| Paratek Pharmaceuticals, INC. | $779.84 | 2020-2025 | Nuzyra |
| Abbvie INC. | $374.70 | 2021-2024 | |
| Paragon 28, INC. | $247.50 | 2021-2022 | |
| Kerecis Limited | $184.58 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Lifenet Health | $182.93 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $154.10 | 2022-2024 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $146.66 | 2019-2020 | |
| Abbott Laboratories | $125.00 | 2023 | Diamondback Peripheral |
| Treace Medical Concepts, INC. | $118.90 | 2024 | |
| Amgen INC. | $116.53 | 2024 | Krystexxa |
| Bioventus LLC | $114.12 | 2023 | Theragenesis Bilayer Wound Matrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $97.42 | 2021 | |
| Next Science LLC | $84.50 | 2024-2025 | Xperience, Blastx, Surgx |
| Polynovo North America LLC | $44.82 | 2024 | Novosorb Btm |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $39.94 | 2021 | |
| Tei Medical INC. | $28.88 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $27.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.51 | 2025 | Austedo Xr |
| Reprise Biomedical, INC. | $23.36 | 2024 | Miro3d |
| Tactile Systems Technology INC | $21.62 | 2025 | Flexitouch Plus, Nimbl |
| Urgo Medical North America, LLC | $21.60 | 2025 | Urgok2 |
| Kci USA, INC. | $18.96 | 2022 | |
| Horizon Therapeutics Plc | $15.73 | 2019 | |
| 3m Company | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marzano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.